The Acute Myeloid Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Silver), and through an educational grant from Jazz Pharmaceuticals. Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
The Chronic Lymphocytic Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), AbbVie (Platinum), BeOne Medicines (Silver) and Lilly (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ASH 2016 | Novel therapies and unique delivery methods to improve treatment for bleeding crises, leukemia
Press brief introduced by Armand Keating, BSc, FRCSC, FRCPC, MD of Princess Margaret Cancer Centre, Toronto, Canada, on ‘Developing novel therapies and unique delivery methods to improve treatment for bleeding crises, leukemia’, at the 2016 American Society of Hematology (ASH) Annual Meeting, held in San Diego, CA.
